References
Bickerstaff ER, Cloake PC. Mesencephalitis and rhombencephalitis. BMJ. 1951;2:77–81.
Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry. 2013;84:576–83.
Odaka M, Yuki N, Yamada M, et al. Bickerstaff's brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barre syndrome. Brain. 2003;126:2279–90.
Wakerley BR, Uncini A, Yuki N, Group GBSC. Guillain–Barre and Miller Fisher syndromes—new diagnostic classification. Nat Rev Neurol. 2014;10:537–44.
Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry. 2001;70:50–5.
Ito M, Kuwabara S, Odaka M, et al. Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum: clinical analysis of 581 cases. J Neurol. 2008;255:674–82.
Hunter G, Young GB, Ang LC. Bickerstaff's brainstem encephalitis presenting to the ICU. Neurocrit Care. 2012;17:102–6.
Alam A, Puri NV. Inefficacy of antipsychotics in treatment of delirium and agitation in two cases of Bickerstaff brainstem encephalitis. J Neuropsychiatry Clin Neurosci. 2014;26:176–8.
Wada Y, Yanagihara C, Nishimura Y, Funakoshi K, Odaka M. Delirium in two patients with Bickerstaff's brainstem encephalitis. J Neurol Sci. 2008;269:184–6.
Terry K, Blum R, Szumita P. Evaluating the transition from dexmedetomidine to clonidine for agitation management in the intensive care unit. SAGE Open Med. 2015;3:2050312115621767.
Narang P, Ianovich F, Sarai SK, Lippmann S. Benefits of dexmedetomidine in management of post-ECT agitation. J ECT. 2017;33:150–1.
Reade MC, O'Sullivan K, Bates S, Goldsmith D, Ainslie WR, Bellomo R. Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial. Crit Care. 2009;13:R75.
Mantz J, Josserand J, Hamada S. Dexmedetomidine: new insights. Eur J Anaesthesiol. 2011;28:3–6.
Czerwonka AI, Herridge MS, Chan L, Chu LM, Matte A, Cameron JI. Changing support needs of survivors of complex critical illness and their family caregivers across the care continuum: a qualitative pilot study of Towards RECOVER. J Crit Care. 2015;30:242–9.
Mansouri P, Javadpour S, Zand F, et al. Implementation of a protocol for integrated management of pain, agitation, and delirium can improve clinical outcomes in the intensive care unit: a randomized clinical trial. J Crit Care. 2013;28:918–22.
Funding
This case report did not receive any finantial support.
Author information
Authors and Affiliations
Contributions
Patient care was done by YH, MEZ and VS. Manuscript drafting was done by YH. Manuscript supervision was done by MEZ and VS.
Corresponding author
Ethics declarations
Ethical Approval
Waived due to a nature of case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Harada, Y., Zaghlouleh, M.E. & Shah, V. Refractory Psychomotor Agitation Responding to Dexmedetomidine Infusion: A Rare Presentation of Bickerstaff Brainstem Encephalitis (BBE). Neurocrit Care 34, 677–681 (2021). https://doi.org/10.1007/s12028-020-01050-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-020-01050-x